Åsa Grauman

Åsa Grauman studies cancer patients' (acute myological leukemia) preferences and perspectives on individualized treatment using algorithms. The research is part of the multidisciplinary VR project MEET-AML, whose goal is to be able to tailor treatment for individual patients using an algorithm that identifies vulnerabilities in leukemia cells' metabolism using -omics data. The project also includes developing ways to integrate patients' preferences, what they want and their own balance between risk and benefit, in the individualized treatment. In her research, she uses preference studies where both qualitative and quantitative methods are included, to understand how people balance their interests and values.

Åsa is also involved in the EU project ENLIGHTENME which studies how urban lighting affects the population's health and well-being. Together with colleagues at CRB, Deborah Mascalzoni and Mirko Ancilotti, Åsa will study the ethical aspects of the project.

Åsa has a master's degree in public health science and has a doctorate in medical science from Uppsala University. Her PhD project was about how people perceive their risk of suffering from heart disease, how people are affected by cardiovascular risk information and their preferences of how risk information should be conveyed. 

E-mail: asa.grauman@crb.uu.se
Phone: +46 18 471 62 44